A biobank is a repository that stores biological samples (usually human) for use in research and medicine. The registration of each sample entering and exiting the system is centrally stored on a computer system that is frequently backed up, and the physical location of each sample is noted to allow efficient location of specimens. Storage of the specimens may range from controlled ambient (room temperature), to +4°C, -20°C, -80°C, and -196°C (liquid or vapor nitrogen, LN2).
Trends, Influencers, and Leaders in Stem Cells and Cord Blood
We’ve posted new content about stem cells and cord blood that I’m excited to share it with you. Let me know what you think!
Do You Know the Top 5 iPS Cell Influencers (Right Now)?
This article considers five of the most influential people operating within the iPS cell marketplace right now. These individuals are renowned industry experts, innovative thought leaders, and of course, highly-sought after speakers, advisers, and board members. Their individual opinions on iPS cell topics can substantially alter public perception…
*Ocata Therapeutics also covered this iPS cell article in an October 3rd press release. Check it out.
CDI, a FUJIFILM company, Announces Launch of World’s Largest Public Stem Cell Bank
On September 1st, Cellular Dynamics International, a FUJIFILM company, announced news that reverberated throughout the stem cell community. The company launched the world’s largest publicly available stem cell bank, the California Institute for Regenerative Medicine (CIRM) hPSC Repository, and the availability of the first 300 iPS cell lines. [Read more…]
3 Bullet Thursday | Stem Cells (Sept 10, 2015)
Stay alert to the latest and greatest on stem cells. Enjoy this week’s “3 Bullet Thursday,” a weekly post that we do to update you on interesting and important events within the world of stem cells.
(1) Do you know the stem cell company that is billionaire Peter Thiel’s largest investment ever in a single company? When a guy worth $3.3 BILLION goes “all in,” you have to take notice.
(2) Announced just two days ago, this news release from the U.S. House is arguably the most important stem cell funding announcement of 2015. Absolutely awesome news. [Read more…]
3 Eerie Similarities between the Acquisition of Cord Blood Registry® (CBR) and ViaCord
Cord Blood Registry® (CBR) recently made headlines by announcing that it had entered into a definitive agreement to be acquired by AMAG Pharmaceuticals for $700M. While the announcement was new, there were aspects of the deal that seemed eerily familiar.
[Read more…]
CBR® Acquisition by AMAG Pharma Further Bolsters Cord Blood Investment Environment
The past few years have seen increasing investments made within the cord blood banking market, both by private equity and venture capital firms. These investments show the strength of the cord blood banking market. A summary of these investors is shown below.
There have also been significant acquisitions made within the cord blood industry, with the largest cord blood bank within the United States, Cord Blood Registry, recently acquired by AMAG Pharmaceuticals in June of 2015 for $700 million. The purchase valued Cord Blood Registry at over 5.55 times revenue and over 15.55 times EBITDA. [Read more…]
- « Previous Page
- 1
- …
- 26
- 27
- 28
- 29
- 30
- 31
- Next Page »